 |
 |
||||||||
 |
 |
 |
 |
 |
|
||||
 |
 |
 |
 |
 |
|
||||
 |
 |
 |
 |
|
|||||
Last Update
PROJECT ADJOURNMENT
Table 1. Collection of DNA samples from IgAN patients, relatives and apparently healthy controls obtained by the IgAN Consortium.
| Partner No. - Local site | IgAN
families No. |
Trios No. |
Biopsy-proven IgAN patients No. |
Controls No. |
| No. 1 - Bari, Italy |
39 (49) |
120 |
556 |
1130 |
| No. 2 - Brescia, Italy |
31 (5) |
47 |
360 |
204 |
| No. 3 - Trieste, Italy |
4 (3) |
6 |
116 |
221 |
| No. 4 - Aachen, Germany |
2 (8) |
39 |
186 |
200 |
| No. 5 - Thessaloniki, Greece |
3 (4) |
36 |
174 |
200 |
| Total samples collected | 79 (69) |
248 |
1392 |
1955 |
Number in brackets represents additional suspected IgAN families. These are families in which one member is affected by biopsy-proven IgAN and others -not biopsied have recurrent macroscopic hematuria episodes in concomitance of upper respiratory tract infections or persistent microscopic hematuria.
Figure 2. Collected DNA samples throughout the years.